A record of what Shiju Koothupalakkal said publicly, with the source. Not advice.
“Recommends buying GlaxoSmithKline Pharmaceuticals at around ₹2018, targeting ₹2130 with a stop loss at ₹1970.”
Shiju Koothupalakkal’s track record (trackable calls only): 7 graded calls · 95% CI 8–64%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
Entry: ₹2,018, as stated.
Target ₹2,130, stop ₹1,970, as stated.
No time frame is stated, so it is tracked until a close reaches ₹2,130 or ₹1,970: there is no fixed window.
Waiting for a close to reach the entry.
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.